Navigation Links
Hormone therapy offers potential protective effect against colon cancer in older women
Date:4/22/2009

DENVER In a large study, a national team of researchers led by Mayo Clinic scientists observed that self-reported use of hormone therapy was associated with a significantly lower colorectal cancer risk. However, the mechanisms for the apparent protective association are still unclear.

The study, being presented at the AACR 100th Annual Meeting 2009, was designed to look at possible links between estrogen exposure and colon cancer molecular subtypes, to determine how these hormones might function as anti-cancer agents.

"In our large, prospective study, use of hormone therapy seemed to be beneficial with respect to reducing colorectal cancer risk women who did use these drugs had a 28 percent lower incidence rate than women who did not use these drugs," says the study's lead author, David Limsui, M.D., a fellow in the Department of Gastroenterology at Mayo Clinic's campus in Rochester, Minn. "But we still don't know how estrogen compounds work in cancer prevention, which is intriguing."

Women who reported using other hormone preparations, such as oral contraceptives, did not appear to derive any colorectal cancer prevention benefits. "Based on our findings, we need to continue exploring the cancer pathways that might be affected by these hormones," Dr. Limsui says.

He adds that other studies have also found that hormone therapy protects postmenopausal women against colon cancer. The largest randomized clinical trial was the 16,000-participant Women's Health Initiative, which concluded in 2004 that combination hormone therapy (estrogen and progestin) reduced a woman's risk of colorectal cancer by about 40 percent, he says. "But few studies have delved deeper to see how these hormones work at the molecular level," Dr. Limsui says.

This investigation is part of the Iowa Women's Health Study, which enrolled 41,836 women from Iowa, aged 55-69, in 1986. After exclusions, the study group consisted of 37,285 women. In the current study, the investigators examined tumor tissue from 553 colorectal cancer patients, specifically looking for associations between self-reported hormone use and a specific DNA methylation pattern, called the CpG island methylator phenotype, or BRAF gene mutations. No associations were detected between hormone use and these molecular markers. Of note, the investigative team previously reported that certain environmental exposures, such as cigarette smoking, might increase colorectal cancer risk through DNA methylation pathways.


'/>"/>

Contact: Karl Oestreich
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Female hormone cycle affects knee joints
2. IROs Help Determine Medical Necessity of Growth Hormone Therapy
3. A potential new target for treatment of hormone refractory prostate cancer
4. Male Hormone Treatment Provider Announces Family Doctor Alert
5. Autism linked with stress hormone levels
6. Organic Left Standing as the Gold Standard for Consumers Looking to Avoid Food Produced With Synthetic Growth Hormones
7. Hormone Reduces Mortality in Heart Patients With High BP
8. Diplomat Specialty Pharmacy Expands National Growth Hormone Patient Care Program - Hires Denise Piro, RN, BSN
9. Hormone Might Help Restore Female Fertility
10. March 2009 Mayo Clinic Womens HealthSource Highlights Molecular Breast Imaging, Canes and Walkers, Training for an Event and Hormone Therapy for Women
11. Male Hormone Replacement Company Renewman.com Critical of MLB for Testosterone Abuse Publicity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... Calif. (PRWEB) , ... March 01, 2017 , ... Award-winning ... has completed 25 medical mission trips in underdeveloped nations, averaging more than one trip ... 2016. An article on the website features the details of his charitable ...
(Date:3/1/2017)... ... March 01, 2017 , ... NYC based Integrated practice Living Well ... to announce the addition of Orthopaedic Surgeon Dr. Donald E. Heitman. Dr. ... Cornell University with a Bachelor of Science degree in biology. He then obtained his ...
(Date:3/1/2017)... ... 01, 2017 , ... “There is Comfort for the Soul”: a loving account ... their all-too-brief time together, and the soul-healing comfort provided by God’s presence in the ... published author, Jerie A. Tau, a dog-loving medical professional whose work takes her to ...
(Date:3/1/2017)... ... ... Way: Key To One Flesh”: a collection of real marital scenarios and solutions for ... Cecilia Chiam, a writer who emigrated to the United States in 1978. , ... problems with the guidance and support of Holy Scripture. , “This is a ...
(Date:3/1/2017)... ... March 01, 2017 , ... Adherence Compliance, the ... Cannabis Compliance Program for Regulatory Agencies. The regulatory agency program is the first ... internal or outsourced compliance program options, as well as an app for inspections ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... Sun Chlorella Corp ., the California -based ... Non-GMO Project Verification and the launch of individual serving packets ... for the Natural Products Expo West trade show, March 10-12 ... Chlorella Corp. has announced the Non-GMO Project Verification logo is ... Sun Chlorella tablets, 250mg and 500mg (20/100-day supplies) ...
(Date:3/1/2017)... March 1, 2017  Integrated Modular Design ... design and implementation of pre-fabricated healthcare products ... room headwalls, seeks to lead the construction ... solutions. Fueled by their leading-edge ... of reducing construction timelines and project risk, ...
(Date:3/1/2017)... , March 1, 2017  Global biotherapeutics leader ... the largest ever Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trial, ... T reatment with H izentra ® ).  ... the efficacy, safety and tolerability of two different doses ... (Immune Globulin Subcutaneous [Human]), compared with placebo, in the ...
Breaking Medicine Technology: